Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Assessing Blood pressure in the Leg

Assessing Blood pressure in the Leg

Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma.

Discover oncology·2026

Same author

Beyond Hemoglobinopathies: Non-Hemoglobinopathy Causes of Transfusion-Dependent Anemia in Children.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026

Same author

<b>A Rare Pediatric Case of Immunodeficiency 76 and its Progression to Acute Myeloid Leukemia</b>.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026

Same author

Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial).

Discover oncology·2026

Same author

Omics-based insights into endophytic <i>Bacillus subtilis</i> (TN FL 158) for blister blight management in <i>Camellia sinensis</i>.

3 Biotech·2026

Same author

Clinical Characteristics, Management, and Outcomes of Pediatric Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Scoping Review.

Pediatric blood & cancer·2026

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?

Manoj Gupta^1,2, G Karthikeyan³, P S Choudhury¹

¹Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Cancer Investigation

|August 18, 2020

Summary

Metastatic castration-resistant prostate cancer (mCRPC) requires palliative care. Theranostic endo-radioligand therapy using Lutetium 177 prostate-specific membrane antigen 617 (Lu-177 PSMA) shows promise for advanced prostate cancer management.

Keywords:

Bench to bedside Lu-177 PSMA Metastatic castration-resistant prostate cancer Radioligand therapy Theranostic

More Related Videos

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Experiment Videos

Last Updated: Jul 24, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Area of Science:

Oncology
Nuclear Medicine
Radiopharmaceutical Therapy

Background:

Metastatic castration-resistant prostate cancer (mCRPC) is an advanced stage of prostate cancer characterized by resistance to standard treatments.
Patients with mCRPC often experience rising PSA levels, bone pain, and significant disease burden, necessitating palliative care strategies.
Effective disease control and improved quality of life are critical goals in managing mCRPC.

Purpose of the Study:

To review the current status and therapeutic potential of Lutetium 177 prostate-specific membrane antigen 617 (Lu-177 PSMA) endo-radioligand therapy for mCRPC.
To discuss the theranostic application of Lu-177 PSMA in the context of advanced prostate cancer treatment.
To explore future directions and advancements in Lu-177 PSMA therapy for mCRPC.

Main Methods:

Review of current literature and clinical data on Lu-177 PSMA therapy for mCRPC.
Analysis of the theranostic principles underlying PSMA-targeted radioligand therapy.
Discussion of patient selection criteria, treatment protocols, and outcomes associated with Lu-177 PSMA.

Main Results:

Lu-177 PSMA therapy represents a novel and promising approach for managing mCRPC.
The theranostic concept allows for targeted delivery of radiation to PSMA-expressing cancer cells.
Emerging data suggest potential benefits in disease control and palliation for selected mCRPC patients.

Conclusions:

Lu-177 PSMA therapy is an evolving treatment modality for metastatic castration-resistant prostate cancer.
Its theranostic application offers a personalized approach to targeted cancer therapy.
Further research and clinical trials are essential to fully establish the role and optimize the use of Lu-177 PSMA in mCRPC management.